USP16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.047900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.241600E-01
Normal-vs-Stage2
1.121600E-02
Normal-vs-Stage3
7.778000E-02
Normal-vs-Stage4
1.074640E-01
Stage1-vs-Stage2
2.770400E-02
Stage1-vs-Stage3
1.485350E-01
Stage1-vs-Stage4
2.400000E-01
Stage2-vs-Stage3
7.398600E-01
Stage2-vs-Stage4
8.824200E-01
Stage3-vs-Stage4
6.699600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.962280E-02
Normal-vs-AfricanAmerican
3.044800E-01
Normal-vs-Asian
3.584200E-02
Caucasian-vs-AfricanAmerican
2.575600E-01
Caucasian-vs-Asian
2.721000E-01
AfricanAmerican-vs-Asian
1.690640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.130400E-02
Normal-vs-Female
2.655900E-02
Male-vs-Female
3.595200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.461200E-01
Normal-vs-Age(41-60Yrs)
2.882500E-02
Normal-vs-Age(61-80Yrs)
2.274300E-02
Normal-vs-Age(81-100Yrs)
4.324400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.447400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.601000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.513000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.737220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.970000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.128800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.459800E-03
Normal-vs-Daily Drinker
1.261770E-03
Normal-vs-Weekly Drinker
4.002300E-02
Normal-vs-Occasional Drinker
8.311800E-02
Normal-vs-Social Drinker
9.679700E-02
Non Drinker-vs-Daily Drinker
6.968000E-02
Non Drinker-vs-Weekly Drinker
7.108600E-01
Non Drinker-vs-Occasional Drinker
6.654600E-01
Non Drinker-vs-Social Drinker
3.791800E-01
Daily Drinker-vs-Weekly Drinker
3.174000E-01
Daily Drinker-vs-Occasional Drinker
8.049700E-02
Daily Drinker-vs-Social Drinker
2.978400E-02
Weekly Drinker-vs-Occasional Drinker
5.563200E-01
Weekly Drinker-vs-Social Drinker
3.584600E-01
Occasional Drinker-vs-Social Drinker
7.371600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.565800E-02
Normal-vs-Grade 2
1.566410E-02
Normal-vs-Grade 3
1.856350E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.120200E-01
Grade 1-vs-Grade 3
2.675200E-01
Grade 1-vs-Grade 4
4.565800E-02
Grade 2-vs-Grade 3
8.904000E-01
Grade 2-vs-Grade 4
1.566410E-02
Grade 3-vs-Grade 4
1.856350E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.679100E-03
Normal-vs-NonDiabetic
1.051580E-02
Diabetic-vs-NonDiabetic
2.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.780800E-03
Normal-vs-NoPancreatitis
1.195760E-02
Pancreatitis-vs-NoPancreatitis
3.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.002620E-01
Normal-vs-N1
7.937700E-03
N0-vs-N1
1.723430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.419810E-02
Normal-vs-TP53-NonMutant
2.583600E-01
TP53-Mutant-vs-TP53-NonMutant
2.156900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
